Tem Group

Munchen, Germany Founded: 2000 • Age: 26 yrs Acquired By Instrumentation Laboratory
Portable devices for hemostasis
Request Access

About Tem Group

Tem Group is a company based in Munchen (Germany) founded in 2000 was acquired by Instrumentation Laboratory in September 2016.. The company has 116 employees as of December 31, 2021. Tem Group operates in a competitive market with competitors including Accriva Diagnostics, Diagnostica Stago, Enzyre, Entegrion and Microvisk, among others.

  • Headquarter Munchen, Germany
  • Employees 116 as on 31 Dec, 2021
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Werfen Gmbh
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Tem Group

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Tem Group

Tem Group has secured backing from 1 investor. Prominent investors backing the company include Instrumentation Laboratory. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Investor Description Founded Year Domain Location
Portfolio of instruments and software solutions for hemostasis testing and critical care
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Tem Group

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Tem Group

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Tem Group Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Tem Group

Tem Group operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Accriva Diagnostics, Diagnostica Stago, Enzyre, Entegrion and Microvisk, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Near-patient diagnostic systems for coagulation testing are developed.
domain founded_year HQ Location
A portfolio of hemostasis and coagulation diagnostic products is manufactured.
domain founded_year HQ Location
Smart diagnostics devices for blood coagulation analysis are developed.
domain founded_year HQ Location
Hemostasis and fluid replacement products are provided for medical applications.
domain founded_year HQ Location
Handheld devices for blood clot monitoring are provided by Microvisk.
domain founded_year HQ Location
Anticoagulant reversal agent and small molecules to prevent allergic reactions, traumatic brain injury.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Tem Group

Frequently Asked Questions about Tem Group

When was Tem Group founded?

Tem Group was founded in 2000.

Where is Tem Group located?

Tem Group is headquartered in Munchen, Germany. It is registered at Munchen, Bayern, Germany.

How many employees does Tem Group have?

As of Dec 31, 2021, the latest employee count at Tem Group is 116.

What does Tem Group do?

Tem group is a medical technology company that is focused on development and production of point-of-care diagnostic equipment and reagents. The company offers its products in 4 business areas: ROTEM diagnostic equipment, reagentsquality control, data solutions, and cuvettesaccessories. Its flagship product ROTEM is a portable device for hemostasis that analyzes whole blood and provides information about all stages of the coagulation process. No pipetting and test preparation is required with the system. The system allows detection of factor deficiency, hyperfibrinolysis, direct FX inhibitors and direct thrombin (FIIa) inhibitor effects and allows easy discrimination between thrombocytopenia and fibrinogen deficiency or fibrin polymerization disorders. The ROTEM delta provides information about Hyperfibrinolysis, Dilutional coagulopathies, Substitution of fibrinogen, Factors or platelets, and the control of heparin or protamine dosage. On September 20, 2016, Tem Group was acquired by Instrumentation Laboratory.

Who are the top competitors of Tem Group?

Tem Group's top competitors include Accriva Diagnostics, Diagnostica Stago and Enzyre.

Who are Tem Group's investors?

Tem Group has 1 investor. Key investors include Instrumentation Laboratory.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available